Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glycosaminoglycans

Glycosaminoglycans

Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

OMERACT 2020: A virtual (R)evolution.

Seminars in arthritis and rheumatism·2021

Same author

Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group.

Seminars in arthritis and rheumatism·2021

Same author

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout.

RMD open·2021

Same author

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.

Seminars in arthritis and rheumatism·2021

Same author

OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study.

Seminars in arthritis and rheumatism·2021

Same author

Epidemiology and Outcomes of Alcohol Use Hospitalizations in People With Gout, Rheumatoid Arthritis, Fibromyalgia, Osteoarthritis, or Low Back Pain: A National US Study.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2021

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

Chondroitin for osteoarthritis.

Jasvinder A Singh¹, Shahrzad Noorbaloochi, Roderick MacDonald

¹Department of Medicine, Birmingham VA Medical Center, Faculty Office Tower 805B, 510 20th Street South, Birmingham, AL, USA, 35294.

The Cochrane Database of Systematic Reviews

|January 29, 2015

Summary

Chondroitin supplements show a small to moderate benefit in reducing osteoarthritis pain and improving joint function in short-term studies. This treatment also demonstrated a lower risk of serious adverse events compared to placebo.

More Related Videos

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

Published on: January 31, 2012

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation

Published on: October 7, 2015

Related Experiment Videos

Last Updated: Apr 18, 2026

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

Published on: January 31, 2012

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation

Published on: October 7, 2015

Area of Science:

Orthopedics
Pharmacology
Rheumatology

Background:

Osteoarthritis (OA) is a leading cause of disability, prompting research into effective treatments.
Chondroitin sulfate is a popular oral supplement for OA, but its efficacy remains debated.
Previous meta-analyses yielded conflicting results, necessitating a current systematic review.

Purpose of the Study:

To systematically evaluate the efficacy and safety of oral chondroitin for osteoarthritis treatment.
To compare chondroitin with placebo and other oral medications, including NSAIDs and glucosamine.
To synthesize evidence from recent randomized controlled trials (RCTs).

Main Methods:

Searched seven major databases up to November 2013 for relevant RCTs.
Included trials of adults with OA, lasting over two weeks, comparing chondroitin to placebo or active controls.
Two independent reviewers assessed titles, extracted data, and evaluated risk of bias.

Main Results:

Forty-three RCTs (4,962 participants on chondroitin, 4,148 on control) were included.
Chondroitin showed statistically significant and clinically meaningful improvements in pain scores (absolute risk difference of 10% lower in studies <6 months) and Lequesne's index (8% lower).
Chondroitin was associated with a statistically significant lower risk of serious adverse events (Peto OR 0.40) compared to placebo.

Conclusions:

Oral chondroitin, alone or with glucosamine, offers short-term benefits for osteoarthritis pain and function.
The observed benefits, though small to moderate, appear clinically meaningful with a favorable safety profile.
Further high-quality research is recommended to clarify chondroitin's role in long-term OA management.